The aim of this work is to compare a biparametrical analysis of DNA using flow cytometry with the monoparametric approach. We analysed 71 samples coming from neoplastic tissue and from non-neoplastic tissue. We compared the average uptake of BrdU (22.37%) with the traditional prognostic parameters. Even if in some cases we found a certain correlation between the traditional prognostic parameters and the average uptake of BrdU, the results are still not encouraging. A final answer can only be supplied after analysing a greater number of cases and after a suitable follow-up period.
TachibanaM., DeguchiN., BabaS., JitsukawaS., HataM., TazakiH.: Prognostic significance of bromodeoxyuridine high labelled bladder cancer measured by flow cytometry: Does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder. J. Urol., 149: 739–743, 1993.
2.
MiyakawaA., TachibanaM., NakashimaJ., DeguchiN., BabaS., TazakiH.: Flow cytometric bromodeoxyuridine/deoxyribonucleic acid bivariate analysis for predicting tumour invasiveness of upper tract urothelial cancer. J. Urol., 152: 76–80, 1994.
3.
TachibanaM., DeguchiN., JitsukawaS., BabaS., HataM., TazakiH.: Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer. J. Urol., 145: 963–967, 1991.
4.
NemotoR., UchidaK., HattoriK., ShimazuiT., NishjimaY., SaitoS., KoisoK., HaradaM.: S phase fraction of human bladder tumour measured in situ with bromodeoxyuridine labelling. J. Urol., 139: 286–289, 1988.
5.
SteenH.B.: Characteristics of flow cytometers. In: Flow Cytometry and Sorting.Wiley-Liss, Inc., 11–25, 1990.
6.
GratznerH.G.: Monoclonal antibody against 5-bro-moand 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science, 218: 474–475, 1982.
7.
VanderlaanM., ThomasC.: Characterization of monoclonal antibodies to bromodeoxyuridine. Cytometry, 6: 501–505, 1985.
8.
DolbeareF., GratznerH., PallaviciniM., GrayJ.: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci., 80: 5573–5577, 1983.
9.
MobilioG., FranzolinN., Tinazzi-MartiniP., BernardiF., ZattiM.: L'indagine citogenetica come indice prognostico nei carcinomi superficiali della vescica. Rapporto preliminare. Urologia, L, 4: 673, 1983.
10.
MobilioG., TribukaitB., FranzolinN., AzzolinaL.S., TridenteG., BianchiG.P., BeltramiP., CurtiP.P.: Prognosis of superficial bladder tumours as studied by DNA flow cytometry, a report on a double blind study of 120 patients. J. of Exp. & Cli. Can. Res., 7: 243, 1988.
